Oldest Concentration-Camp Survivor Dies at Age 108 and First Time In History": Cancer Vanishes For Every Patient In Drug Trial and Lab-generated sperm created at Israeli university and Jokes about Bible figures

View in browser Yehuda Lave is an author, journalist, psychologist, rabbi, spiritual teacher, and coach, with degrees in business, psychology and Jewish Law. He works with people from all walks of life and helps them in their search for greater happiness, meaning, business advice on saving money, and spiritual engagement. Love Yehuda Lave Join my blog by sending me an email to YehudaLave@gmail.com The Three Musketeers at the Kotel The Three are Rabbi Yehuda Glick, famous temple mount activist, and former Israel Mk, and then Robert Weinger, the world's greatest shofar blower and seller of Shofars, and myself after we had gone to the 12 gates of the Temple Mount in 2020 to blow the shofar to ask G-d to heal the world from the Pandemic. It was a highlight to my experience in living in Israel and I put it on my blog each day to remember. The articles that I include each day are those that I find interesting, so I feel you will find them interesting as well. I don't always agree with all the points of each article but found them interesting or important to share with you, my readers, and friends. It is cathartic for me to share my thoughts and frustrations with you about life in general and in Israel. As a Rabbi, I try to teach and share the Torah of the G-d of Israel as a modern Orthodox Rabbi. I never intend to offend anyone but sometimes people are offended and I apologize in advance for any mistakes. The most important psychological principle I have learned is that once someone's mind is made up, they don't want to be bothered with the facts, so, like Rabbi Akiva, I drip water (Torah is compared to water) on their made-up minds and hope that some of what I have share sinks in. Love Rabbi Yehuda Lave. Oldest Concentration-Camp Survivor Dies at Age 108 Boris Pahor, June 20, 2015. The oldest known survivor of a Nazi concentration camp, Boris Pahor, died on Monday in the Italian city of Trieste at the age of 108, reported Deutsche Welle. Pahor was born on Aug. 26, 1913, in the city of Trieste, which belonged to the Austro-Hungarian Empire at the time. He was part of the Slovenian minority in the city and fought with the Slovenian resistance against the Nazi occupation during World War II. He was arrested by the Nazis in 1944 and deported to Dachau, which he survived along with four other Nazi concentration camps: Natzweiler-Struthof, Dora-Mittelbau, Harzungen and Bergen-Belsen. Pahor published the autobiographical novel Necropolis in 1967 about the horrors of the Holocaust. He also wrote Flowers for a Leper (2004) and Piazza Oberdan (2006) about the brutality of Italian fascists towards the Slovenian minority in Trieste, and A Difficult Spring (1978), based on his experience of moving to Paris after the war. The Holocaust survivor was a recipient of Slovenia's highest award for cultural achievement in 1991 and was appointed to the country's Academy of Sciences and Arts. In one of his last public appearances, he talked about the importance of remembering the Holocaust, saying, "I wanted to testify and explain what I experienced so that others can learn how and what can happen." Italian President Sergio Mattarella praised Pahor as a "witness and victim of the horrors caused by war, by inflated nationalism and totalitarian ideologies." The country's culture minister, Dario Franceschini, paid tribute to Pahor saying, "we have lost a great writer, a giant of the 20th century who was able to tell the horrors of the concentration camp with skill and clarity, pulling no punches." First Time In History": Cancer Vanishes For Every Patient In Drug Trial 18 rectal cancer patients were given the same drug for six months and as a result of the treatment, cancer was completely obliterated in every patient. Larger-scale trials are still needed to see if it will work for more patients. (Representative) A small group of people with rectal cancer just experienced something of a miracle as their cancer simply vanished after an experimental treatment. According to New York Times, in a very small clinical trial, 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of them saw their tumours disappear. Dostarlimab is a drug with laboratory-produced molecules that act as substitute antibodies in the human body. All 18 rectal cancer patients were given the same drug and as a result of the treatment, cancer was completely obliterated in every patient - undetectable by physical exam; endoscopy; positron emission tomography or PET scans or MRI scans. Dr Luis A. Diaz J. of New York's Memorial Sloan Kettering Cancer Center said this was "the first time this has happened in the history of cancer". As per New York Times, the patients involved in the clinical trial faced gruelling previous treatments to obliterate their cancer, such as chemotherapy, radiation and invasive surgery that could result in bowel, urinary and even sexual dysfunction. The 18 patients went into the trial expecting to have to go through these as the next step. However, to their surprise, no further treatment was needed. The findings are now making waves in the medical world. Speaking to the media outlet, Dr Alan P. Venook, who is a colorectal cancer specialist at the University of California, said that the complete remission in every single patient is "unheard-of". He hailed the research as a world-first. He even noted that it was especially impressive as not all of the patients suffered significant complications from the trial drug. Separately, Memorial Sloan Kettering Cancer Center and a co-author of the paper, oncologist Dr Andrea Cercek, described the moment patients found out they were cancer-free. "There were a lot of happy tears," she told the New York Times. For the trial, patients took Dostarlimab every three weeks for six months. They were all in similar stages of their cancer - it was locally advanced in the rectum but had not spread to other organs. RABBI SCHWARTZ'S TERRIBLE TORAH FIGURES JOKES OF THE WEEK What did David call himself after his ID was stolen? Dav… Who was the greatest financier in the Bible? Noach -- he was floating his stock while everyone else was liquidating. Who was the greatest female financier in the Bible? Pharaoh's daughter -- she went down to the bank of the Nile and drew out a little "prophet". Yitzhak had just moved into a new apartment and was out celebrating with his friend Benny. At 2am, he invited Benny back to his apartment where they continued to celebrate. Then Benny said, "Before I go, why not show me around?" So Yitzhak proudly showed Benny his apartment and all the high tech it contained. Then he took Benny into his bedroom where his friend couldn't help but notice a very large shofar on the chest of drawers. "Why do you have a shofar in your bedroom?" asked Benny. "That's my clock," Yitzhak replied. "A clock? Are you serious?" said Benny. "Of course," replied Yitzhak. "So how does it work?" said Benny. "Watch this," replied Yitzhak, as he picked up the shofar and blew it at the top of his lungs. They stood looking at each other for a moment when suddenly, someone in the apartment next door screamed, "Stop that, you inconsiderate oaf. It's quarter to three in the morning." What kind of man was Boaz before he got married? Ruth-less. What excuse did Adam give to his children as to why he no longer lived in Eden? "Your mother ate us out of house and home" The ark was built in three stories. The top one had a window to let in light. How did the bottom two stories get light? They used floodlights. Why was Goliath so surprised when David hit him with a slingshot? The thought had Who was the first person to download something from a cloud to two tablets? Moses Where is the first tennis match mentioned in the Bible? When Joseph served in Pharaoh's court. Which Bible character had no parents? Joshua, son of Nun How do we know the people on the ark with Noah did not play card games? Because Noah sat on the deck A Surgeon, an engineer, and a politician were arguing as to which profession was older. "Well," argued the Surgeon, "G‑d created Eve from Adam by form of surgery, so I am sure that mine is the oldest profession." "No," said the engineer, "before life began there was complete chaos, and it took an engineer to create some semblance of order from this chaos. So engineering is older." But," chirped the triumphant politician, "who do you think created the chaos?" Yankel came to a bar on a nightly basis, ordering two glasses of Crown Royal. When the bartender asked him why he never changed his order, the man explained that he had a friend with whom he drank a nightly glass of Crown Royal for many years. "My Berel was drafted and died in Korea," the man sighed, "and I decided to immortalize him by drinking two glasses of Crown Royal every night. One glass I drink for him; the other for myself." One night, after thirty years, the man entered the bar and ordered a single glass of Crown Royal. "What happened?" asked the bartender. "Oh," Yankel responded, "I quit drinking." Lab-generated sperm created at Israeli university Researchers at Ben-Gurion University built a 3D model and tested it on young mice. After 5-7 weeks, sperm cells in the process of developing were discovered. Ben-Gurion University of the Negev (BGU) researchers have developed a means of creating sperm cells in a laboratory – marking a potential breakthrough in the fields of fertility and reproductive science. How did they do it, and what did they find? The BGU research, which was published in the peer-reviewed journal Biofabrication, had researchers develop a procedure for culturing testicular cells in an environment that closely resembled a natural one. Located in Beer Sheba, BGU is renowned for its research departments across medical and scientific fields. Researchers built a 3D model and tested it on young mice who were not yet capable of producing sperm – and after 5-7 weeks, sperm cells in the process of developing were discovered in the model, marking the success of the experiment. "This system may also serve as an innovative platform for examining the effect of drugs and toxins on male fertility" Prof. Mahmoud Huleihel, BGU's Faculty of Health Sciences "This study opens up a new horizon in the process of creating sperm cells in a culture," says study co-author Prof. Mahmoud Huleihel from BGU's Faculty of Health Sciences. "It enables the implementation of microfluidic-based technologies in future therapeutic strategies for infertile men and in the preservation of fertility for children undergoing aggressive chemotherapy/radiotherapy treatments that may impair their fertility in puberty." Why is this a breakthrough? Children with cancer who receive aggressive chemotherapy are among the cohorts that may lose their fertility in the future. Preserving fertility among these children and treating infertile men are issues that concern many researchers around the world – and led to the BGU study's advancement. "This system may also serve as an innovative platform for examining the effect of drugs and toxins on male fertility," Huleihel added. See you tomorrow bli neder We need Moshiach now! Love Yehuda Lave Yehuda Lave, Spirtual Advisor and Counselor Jerusalem, Jerusalem  Israel 972-585043210 YehudaLave@gmail.com You received this email because you signed up on our website or made a purchase from us. Unsubscribe